Montelukast Sodium
Who holds supplier records for Montelukast Sodium? 21 organisations hold a current record for Montelukast Sodium: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (15), China (2), Netherlands (1), Taiwan (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Montelukast Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/montelukast-sodium
Reading the evidence
- 21 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
15 of the 20 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 11 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (21)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Montelukast Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 43282, 27234 · latest filing Feb 2026
- MSN PHARMACHEM PRIVATE LTDIndiaCEPActive DMF 22484, 20580, 27041 · latest filing May 2013
- TAPI NL BVNetherlandsCEPActive DMF 31413, 19829 · latest filing May 2017
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 20035, 24516 · latest filing Dec 2010
- Formosa Laboratories, Inc.TaiwanCEP Company GMP cert on recordActive DMF 21702 · latest filing Jun 2008
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 24667 · latest filing Feb 2011
- Laurus Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 23736 · latest filing Apr 2010
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 25104 · latest filing Jul 2011
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20425 · latest filing Mar 2007
- MELODY HEALTHCARE PVT LTDIndiaCEPActive DMF 25823 · latest filing Oct 2011
- MOREPEN LABORATORIES LTDIndiaCEP Company GMP cert on recordActive DMF 24445 · latest filing Dec 2010
- Shandong New Time Pharmaceutical Co LtdCEP Company GMP cert on recordActive DMF 33973 · latest filing Aug 2019
- Zhejiang Tianyu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 32307 · latest filing Mar 2018
- Apotex Inc.CanadaActive DMF 23495 · latest filing Jan 2010
- CHINA GATEWAY PHARMACEUTICAL DEVELOPMENT CO LTDChinaActive DMF 28547 · latest filing Jul 2014
- Cipla LimitedIndia Company GMP cert on recordActive DMF 28087 · latest filing Mar 2014
- Torrent PharmaceuticalsIndia Company GMP cert on recordActive DMF 24721 · latest filing Apr 2011
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 33163 · latest filing Sept 2018
- UNIMARK REMEDIES LTDIndiaActive DMF 23837, 24324, 20564 +2 · latest filing Nov 2012
- ZENFOLD SUSTAINABLE TECHNOLOGIES PRIVATE LTDIndiaActive DMF 39191 · latest filing Dec 2023
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Montelukast Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 24 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2026-108 - Rev 00 Montelukast sodium, Process-II, LT code | Nov 2026 | — |
| MSN PHARMACHEM PRIVATE LIMITED Sangareddy | IN | CEP 2012-091 - Rev 02 Montelukast sodium, Amorphous, Micronised, Non-micronised and Sifted | Jun 2026 | — |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | CEP 2024-125 - Rev 00 Montelukast sodium | Dec 2025 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2011-245 - Rev 04 Montelukast sodium | Oct 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2011-131 - Rev 03 Montelukast sodium | Mar 2025 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2024-390 - Rev 00 Montelukast sodium, 1556 | Feb 2025 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2012-318 - Rev 02 Montelukast sodium | Dec 2024 | — |
| MOREPEN LABORATORIES LIMITED Baddi | IN | CEP 2012-003 - Rev 02 Montelukast sodium, Milled and micronised | Dec 2024 | Inspected Mar 2026 Spain |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2013-311 - Rev 02 Montelukast sodium, Alternate process | Nov 2024 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2012-115 - Rev 03 Montelukast sodium | Jul 2023 | — |
| MELODY HEALTHCARE PVT. LTD. Boisar | IN | R1-CEP 2011-319 - Rev 02 Montelukast sodium | Feb 2023 | — |
| SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. Linyi | CN | R0-CEP 2019-211 - Rev 00 Montelukast sodium | Jun 2022 | — |
| FORMOSA LABORATORIES, INC. Taoyuan | TW | R1-CEP 2013-278 - Rev 00 Montelukast sodium | Jul 2021 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | R1-CEP 2014-115 - Rev 01 Montelukast sodium | Jul 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Montelukast Sodium are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- India · Inactive DMF 25568 · filed Dec 2011
- South Korea · Inactive DMF 25546 · filed Nov 2011
- PHARMACEUTICAL WORKS POLPHARMA SAInactive DMF 25061 · filed Jun 2011
- India · Inactive DMF 24588 · filed Mar 2011
- SINTENOVO SA DE CVInactive DMF 24747 · filed Mar 2011
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Montelukast Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200681).
Chemical identity
- IUPAC name
- sodium 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
- Canonical SMILES
- CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+]
- InChIKey
- LBFBRXGCXUHRJY-HKHDRNBDSA-M
- Synonyms
- MK-476, Montelukast (as sodium), Montelukast monosodium salt, Montelukast sodium, NSC-759107, Singulair
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Leukotriene Receptor Antagonist
- Mechanism of action
- Leukotriene Receptor Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Montelukast Sodium?
21 organisations hold an active US FDA Type II Drug Master File or a CEP for Montelukast Sodium: APITORIA PHARMA PRIVATE LTD (India), MSN PHARMACHEM PRIVATE LTD (India), TAPI NL BV (Netherlands), Dr. Reddy's Laboratories Ltd. (India), Formosa Laboratories, Inc. (Taiwan), Hetero Drugs Limited (India), Laurus Labs Limited (India) and Macleods Pharmaceuticals Ltd. (India), and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Montelukast Sodium Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 43282, 27234), MSN PHARMACHEM PRIVATE LTD (DMF 22484, 20580), TAPI NL BV (DMF 31413, 19829), Dr. Reddy's Laboratories Ltd. (DMF 20035, 24516), Formosa Laboratories, Inc. (DMF 21702), Hetero Drugs Limited (DMF 24667), Laurus Labs Limited (DMF 23736) and Macleods Pharmaceuticals Ltd. (DMF 25104) and 12 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Montelukast Sodium records mean?
5 organisations have only inactive Type II DMFs for Montelukast Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Montelukast Sodium have a European Certificate of Suitability?
Yes. 14 organisations hold a valid CEP for Montelukast Sodium on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), TAPI NL B.V. Amsterdam (NL) and MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Montelukast Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Montelukast Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.